Enrique Grande, One Oncology Madrid Program Director at Quironsalud, shared on X:
“Risk model to predict BCG-unresponsive disease or progression in HG Ta/T1 NMIBC (n=2,211; 13 centers).
Five independent predictors: T1 stage, residual HG/T1 at re-TURBT, multifocality, concomitant CIS, and WHO grade 3.
Outperforms EORTC and EAU 2021 stratification – with a free web calculator available.”
Title: Predicting the Development of BCG-unresponsive Disease Among Patients with High-grade Non–muscle-invasive Bladder Cancer: An International Multicenter Analysis
Authors: Aleksander Ślusarczyk, Marco Moschini, Wojciech Krajewski, Pietro Scilipoti, Roberto Contieri, Francesco Claps, José Daniel Subiela, Laura S. Mertens, Keiichiro Mori, Jorge Caño Velasco, Francesco Soria, Elisabeth Grobet-Jeandin, Karl Tully, Karolina Garbas, Pedro Del Olmo Durán, Renee A.G. Lijnen, Giorgia Fertitta, Maxence Reynard, Olga Katzendorn, Alfonso Lafuente Puentedura, Mattia Longoni, David D’Andrea, Francesco Del Giudice, Andrea Gallioli, Ekaterina Laukhtina, Gautier Marcq, Andrea Mari, Luca Afferi, Simone Albisinni, Antonio Amodeo, Stephen A. Boorjian, Alberto Briganti, Francesco Montorsi, Shahrokh F. Shariat, Paolo Gontero, Piotr Radziszewski, Benjamin Pradere
You can also read:
